STORMS microbiome reporting checklist. by Katrine Carlsen (5477300)

Database indexing study information, intervention description, and reported and calculated statistics for all studies included in analyses. by Jessica Craig (409538)

Subjects:

Significant change in self-reported behaviour between Pre-Test (T1) to Follow-Up (T3). by Michelle McNab (6984125)

“…Significant decrease in the number of sweets consumed per day was identified. c) Instances of tobacco use reported at T1 and T3. …”

Supplementary Material for: Decrease in mycophenolic acid plasma level by sacubitril/valsartan in lupus nephritis patient: a case report by Nashimoto S. (17866511)

“…Mycophenolate mofetil (MMF), an inactive prodrug of mycophenolic acid (MPA), is an immunosuppressive drug used widely in the treatment of lupus nephritis. In this case report, the area under the blood concentration time curve (AUC) of MPA was significantly decreased by the concomitant use of sacubitril/valsartan. …”

Cost-effectiveness rankings report of the model. by Sangwook Park (379863)

Subjects:

Gap junction (GJ) communication decreases the proportion of cells exhibiting Ca²⁺ spikes. by Dharsan K. Soundarrajan (11632145)

The DR-<i>white</i> DNA double-strand break (DSB) reporter assay. by Elizabeth L. Graham (18462018)

Activities reported to impact SWB the most the past four weeks and Yesterday’s Activities. by August Håkan Nilsson (12937056)

Subjects:

Bexarotene pretreatment significantly suppressed HBV and HDV infections in primary human hepatocytes (PHH). by Sameh A. Gad (12269979)

Causes of death as recorded in medical chart reported as percent of total deaths. by Marc S. Penn (16624541)

Stated decrease in saiga horn usage following the intervention for those with accurate intervention recall. by Hunter Doughty (7365629)

Consolidated Standards of Reporting Trials (CONSORT) flow diagram. by Adeel A. Faruki (13839691)

Scores, change in the measures of interest, and <i>p</i>-values for binomial tests of significance in change in scores before and since the pandemic began. by Stacey Giroux (13607651)

Subjects:

Changes in reported rate of AEFIs in the pre-LAW and post-LAW period(/10000). by Chao Zhang (51048)

Subjects:

Basic information and patient characteristics according to the report. by Xiaoling Zhong (181270)

Subjects:

Effect of interventions on clinical outcomes (ICU admission rate, adverse events, mortality, readmission or return visit to a health facility, recurrence of infection, and treatmen... by Jessica Craig (409538)

Subjects:

Effect of interventions on antimicrobial use (proportion of patients receiving antimicrobials). by Jessica Craig (409538)

Subjects:

Funnel plot demonstrating lack of publication bias across all studies that met our review’s inclusion criteria. by Jessica Craig (409538)

Subjects:

Effect of interventions on the proportion of isolates/infections resistant to various antimicrobials. by Jessica Craig (409538)

Subjects:

Flow diagram of systematic literature review describing behavior change interventions to improve antimicrobial use and stewardship in the animal and human health sectors. by Jessica Craig (409538)

Subjects: